| Univariable | Multivariable | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (y) | Â | Â | Â | Â |
 > 50 | Ref. |  | Ref. |  |
 ≤ 50 | 3.67 (1.04–12.99) | 0.044 | 12.73 (1.18–137.51) | 0.036 |
Palpable mass or bloody nipple discharge | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 1.90 (0.71–5.10) | 0.203 | 0.95 (0.22–4.10) | 0.940 |
Clinical tumor size, median (range), cm | 1.18 (0.96–1.45) | 0.114 | 1.44 (0.99–2.08) |  |
Suspicious axillary lymph node on radiologic evaluation | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 9.07 (3.10–26.52) | < 0.001 | 9.31 (2.06–41.99) | 0.004 |
Suspicious microcalcification on radiologic evaluation | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 1.08 (0.37–3.13) | 0.891 | 4.14 (0.45–37.83) | 0.208 |
Nuclear grade*,†|  | 0.525 |  | 0.290 |
 Low | Ref. |  | Ref. |  |
 Intermediate | 2.06 (0.25–17.10) | 0.505 | 2.93 (0.20–42.43) | 0.431 |
 High | 3.21 (0.37–28.26) | 0.293 | 11.14 (0.40–308.25) | 0.155 |
Comedo necrosis*,†|  |  |  |  |
 No | Ref. |  | Ref. |  |
 Yes | 1.00 (0.29–3.50) | 0.998 | 0.41 (0.06–2.71) | 0.357 |
Hormone receptor§ |  |  |  |  |
 Negative | Ref. |  | Ref. |  |
 Positive | 1.55 (0.43–5.54) | 0.503 | 0.42 (0.03–5.19) | 0.498 |
HER2§ |  |  |  |  |
 Negative | Ref. |  | Ref. |  |
 Positive | 0.27 (0.06–1.23) | 0.090 | 0.30 (0.04–2.59) | 0.276 |
Ki-67 (%) § |  |  |  |  |
 < 14% | Ref. |  | Ref. |  |
 ≥ 14% | 1.58 (0.56–4.47) | 0.385 | 0.62 (0.07–5.84) | 0.676 |